De novo synthesis of five yeast chromosomes – Phys.Org
Phys.Org |
De novo synthesis of five yeast chromosomes
Phys.Org This sentence taken from Richard Feynman’s board at the time of his death essentially captures, if applied to a biological frame, the holy grail of synthetic biology; the understanding of life to such an extent that living systems can be rationally … |
|
Vision loss after intravitreal injection of autologous ‘stem cells‘ for AMD
Pharmacy Today, American Pharmacists Association, pharmacist.com In a new report, researchers present the cases of three women who developed severe bilateral visual loss after they received intravitreal injections of autologous adipose tissue–derived “stem cells” at a stem–cell clinic in the United States. The … |
|
Cell Medica Raises £60M for Phase II T–Cell Product and Cell Immunotherapy Pipeline
Genetic Engineering & Biotechnology News Cell Medica is exploiting its activated cytotoxic T cell technology, and chimeric antigen receptor (CAR), and engineered T cell receptors (TCR) platforms to develop a pipeline of cell-based immunotherapies for applications in cancer therapy and immune … Cell Medica: £60 Million Series C Financing to Advance Multiple Cancer ProgrammesYahoo Finance |
Bdaily |
UK Immunotherapy Biotech raises Massive Funding in Series C
Labiotech.eu (blog) The UK biotech Cell Medica picked up a massive €69M (£60M) in its recent Series C funding round to advance its cancer immunotherapy programs. Cell Medica is a clinical stage company developing cell-based therapies to treat cancer. With the aim of … Cell Medica Raises £60M for Phase II T-Cell Product and Cell Immunotherapy PipelineGenetic Engineering & Biotechnology News Cell Medica: £60 Million Series C Financing to Advance Multiple Cancer ProgrammesYahoo Finance Cell Medica’s £60m Series C has potential to ‘transform’ cancer treatmentBdaily |
OncLive |
Immunotherapy, Emerging Agents Offer Hope in GI Cancers
OncLive “I don’t think we have hit the big one yet, but we are on the cusp of seeing some real improvements in how patients are doing, particularly with immunotherapy combinations and modifying immunotherapies, so it works for more patients with GI cancers.” |
|
Tech wrap: Duke Twitter hack; Tesla raising $1B; stem cell blindness; in-flight headphone explosion; China patent surge
WRAL Tech Wire Hundreds of Twitter accounts have been hijacked amid the ongoing diplomatic feud between Turkey and two European nations, Germany and the Netherlands. It’s not clear how many accounts were taken over altogether but a slew of them, ranging from … |
|
USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR …
P&T Community “This is the fourth time that our US Patent for Production of Allogeneic TCR-Deficient CAR–T cells is challenged and each time, the USPTO has been favorable to Celyad. This patent is key for the players that are developing in the US allogeneic CAR–T … |
|
USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR …
Business Wire (press release) 9,181,527, relating to allogeneic human primary T-cells that are engineered to be TCR-deficient and express a CAR. The patent remains valid and enforceable. “This is the fourth time that our US Patent for Production of Allogeneic TCR-Deficient CAR–T … |